Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 179

1.

Increasing tolerance of hospital Enterococcus faecium to handwash alcohols.

Pidot SJ, Gao W, Buultjens AH, Monk IR, Guerillot R, Carter GP, Lee JYH, Lam MMC, Grayson ML, Ballard SA, Mahony AA, Grabsch EA, Kotsanas D, Korman TM, Coombs GW, Robinson JO, Gonçalves da Silva A, Seemann T, Howden BP, Johnson PDR, Stinear TP.

Sci Transl Med. 2018 Aug 1;10(452). pii: eaar6115. doi: 10.1126/scitranslmed.aar6115.

PMID:
30068573
2.

Antibiotic allergy testing improves antibiotic appropriateness in patients with cancer.

Trubiano JA, Grayson ML, Phillips EJ, Stewardson AJ, Thursky KA, Slavin MA.

J Antimicrob Chemother. 2018 Jul 27. doi: 10.1093/jac/dky307. [Epub ahead of print] No abstract available.

PMID:
30060208
3.

How antibiotic allergy labels may be harming our most vulnerable patients.

Trubiano JA, Grayson ML, Thursky KA, Phillips EJ, Slavin MA.

Med J Aust. 2018 Jun 18;208(11):469-470. No abstract available.

PMID:
29902399
4.

Superbugs in the supermarket? Assessing the rate of contamination with third-generation cephalosporin-resistant gram-negative bacteria in fresh Australian pork and chicken.

McLellan JE, Pitcher JI, Ballard SA, Grabsch EA, Bell JM, Barton M, Grayson ML.

Antimicrob Resist Infect Control. 2018 Feb 23;7:30. doi: 10.1186/s13756-018-0322-4. eCollection 2018.

5.

Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis.

Tacconelli E, Carrara E, Savoldi A, Harbarth S, Mendelson M, Monnet DL, Pulcini C, Kahlmeter G, Kluytmans J, Carmeli Y, Ouellette M, Outterson K, Patel J, Cavaleri M, Cox EM, Houchens CR, Grayson ML, Hansen P, Singh N, Theuretzbacher U, Magrini N; WHO Pathogens Priority List Working Group.

Lancet Infect Dis. 2018 Mar;18(3):318-327. doi: 10.1016/S1473-3099(17)30753-3. Epub 2017 Dec 21.

PMID:
29276051
6.

The Combined Utility of Ex Vivo IFN-γ Release Enzyme-Linked ImmunoSpot Assay and In Vivo Skin Testing in Patients with Antibiotic-Associated Severe Cutaneous Adverse Reactions.

Trubiano JA, Strautins K, Redwood AJ, Pavlos R, Konvinse KC, Aung AK, Slavin MA, Thursky KA, Grayson ML, Phillips EJ.

J Allergy Clin Immunol Pract. 2018 Jul - Aug;6(4):1287-1296.e1. doi: 10.1016/j.jaip.2017.09.004. Epub 2017 Oct 31.

7.

The 3 Cs of Antibiotic Allergy-Classification, Cross-Reactivity, and Collaboration.

Trubiano JA, Stone CA, Grayson ML, Urbancic K, Slavin MA, Thursky KA, Phillips EJ.

J Allergy Clin Immunol Pract. 2017 Nov - Dec;5(6):1532-1542. doi: 10.1016/j.jaip.2017.06.017. Epub 2017 Aug 23. Review. Erratum in: J Allergy Clin Immunol Pract. 2018 Jan - Feb;6(1):323.

8.

Impact of an Integrated Antibiotic Allergy Testing Program on Antimicrobial Stewardship: A Multicenter Evaluation.

Trubiano JA, Thursky KA, Stewardson AJ, Urbancic K, Worth LJ, Jackson C, Stevenson W, Sutherland M, Slavin MA, Grayson ML, Phillips EJ.

Clin Infect Dis. 2017 Jul 1;65(1):166-174. doi: 10.1093/cid/cix244. Review.

9.

Antibiotic Allergy Labels in a Liver Transplant Recipient Study.

Khumra S, Chan J, Urbancic K, Worland T, Angus P, Jones R, Grayson ML, Trubiano JA.

Antimicrob Agents Chemother. 2017 Apr 24;61(5). pii: e00078-17. doi: 10.1128/AAC.00078-17. Print 2017 May. No abstract available.

10.

More Doctor-Patient Contact Is Not the Only Explanation For Lower Hand-Hygiene Compliance in Australian Emergency Departments.

Stewardson AJ, Stuart RL, Marshall C, Cruickshank M, Grayson ML.

Infect Control Hosp Epidemiol. 2017 Apr;38(4):502-504. doi: 10.1017/ice.2016.336. Epub 2017 Feb 9. No abstract available.

PMID:
28179031
11.

Evolutionary origins of the emergent ST796 clone of vancomycin resistant Enterococcus faecium.

Buultjens AH, Lam MM, Ballard S, Monk IR, Mahony AA, Grabsch EA, Grayson ML, Pang S, Coombs GW, Robinson JO, Seemann T, Johnson PD, Howden BP, Stinear TP.

PeerJ. 2017 Jan 24;5:e2916. doi: 10.7717/peerj.2916. eCollection 2017.

12.

Core components for effective infection prevention and control programmes: new WHO evidence-based recommendations.

Storr J, Twyman A, Zingg W, Damani N, Kilpatrick C, Reilly J, Price L, Egger M, Grayson ML, Kelley E, Allegranzi B; WHO Guidelines Development Group.

Antimicrob Resist Infect Control. 2017 Jan 10;6:6. doi: 10.1186/s13756-016-0149-9. eCollection 2017.

13.

Improving Antimicrobial Stewardship by Antibiotic Allergy Delabeling: Evaluation of Knowledge, Attitude, and Practices Throughout the Emerging Infections Network.

Trubiano JA, Beekmann SE, Worth LJ, Polgreen PM, Thursky KA, Slavin MA, Grayson ML, Phillips EJ.

Open Forum Infect Dis. 2016 Sep 3;3(3):ofw153. eCollection 2016 Sep.

14.

Measuring infections in Australia: simple yet frustrating.

Grayson ML.

Lancet Infect Dis. 2017 Jan;17(1):9-10. doi: 10.1016/S1473-3099(16)30392-9. Epub 2016 Oct 24. No abstract available.

PMID:
27789180
15.

Poor reporting and documentation in drug-associated Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis - Lessons for medication safety.

Goldblatt C, Khumra S, Booth J, Urbancic K, Grayson ML, Trubiano JA.

Br J Clin Pharmacol. 2017 Feb;83(2):224-226. doi: 10.1111/bcp.13103. Epub 2016 Oct 4. No abstract available.

16.

Antimicrobial allergy 'labels' drive inappropriate antimicrobial prescribing: lessons for stewardship.

Trubiano JA, Chen C, Cheng AC, Grayson ML, Slavin MA, Thursky KA; National Antimicrobial Prescribing Survey (NAPS).

J Antimicrob Chemother. 2016 Jun;71(6):1715-22. doi: 10.1093/jac/dkw008. Epub 2016 Feb 18.

PMID:
26895771
17.

Is Aerosolized Pentamidine for Pneumocystis Pneumonia Prophylaxis in Renal Transplant Recipients Not as Safe as We Might Think?

Macesic N, Urbancic K, Ierino F, Grayson ML.

Antimicrob Agents Chemother. 2016 Mar 25;60(4):2502-4. doi: 10.1128/AAC.02290-15. Print 2016 Apr.

18.

Acute Flaccid Paralysis: The New, The Old, and The Preventable.

Macesic N, Hall V, Mahony A, Hueston L, Ng G, Macdonell R, Hughes A, Fitt G, Grayson ML.

Open Forum Infect Dis. 2015 Dec 9;3(1):ofv190. doi: 10.1093/ofid/ofv190. eCollection 2016 Jan. Erratum in: Open Forum Infect Dis. 2017 Aug 05;4(3):ofx019.

19.

Reply to Davido and Dinh.

Grayson ML, Macesic N, Trevillyan J.

Clin Infect Dis. 2016 Mar 1;62(5):672. doi: 10.1093/cid/civ967. Epub 2015 Dec 20. No abstract available.

PMID:
26689958
20.

Use of an Innovative Personality-Mindset Profiling Tool to Guide Culture-Change Strategies among Different Healthcare Worker Groups.

Grayson ML, Macesic N, Huang GK, Bond K, Fletcher J, Gilbert GL, Gordon DL, Hellsten JF, Iredell J, Keighley C, Stuart RL, Xuereb CS, Cruickshank M.

PLoS One. 2015 Oct 21;10(10):e0140509. doi: 10.1371/journal.pone.0140509. eCollection 2015.

21.

Fever in melanoma: new drugs or bugs?

Macesic N, Ameratunga M, Grayson ML, Johnson DF.

Clin Microbiol Infect. 2015 Oct;21(10):e77-8. doi: 10.1016/j.cmi.2015.06.020. Epub 2015 Jun 25. No abstract available.

22.

Fosfomycin for Treatment of Prostatitis: New Tricks for Old Dogs.

Grayson ML, Macesic N, Trevillyan J, Ellis AG, Zeglinski PT, Hewitt NH, Gardiner BJ, Frauman AG.

Clin Infect Dis. 2015 Oct 1;61(7):1141-3. doi: 10.1093/cid/civ436. Epub 2015 Jun 10.

PMID:
26063723
23.

Optimal timing of oral fosfomycin administration for pre-prostate biopsy prophylaxis.

Rhodes NJ, Gardiner BJ, Neely MN, Grayson ML, Ellis AG, Lawrentschuk N, Frauman AG, Maxwell KM, Zembower TR, Scheetz MH.

J Antimicrob Chemother. 2015 Jul;70(7):2068-73. doi: 10.1093/jac/dkv067. Epub 2015 Mar 22.

PMID:
25802286
24.

Vancomycin vintage: my favourite DRESS.

Korman TM, Turnidge JD, Grayson ML.

Intern Med J. 2015 Feb;45(2):233-4. doi: 10.1111/imj.12660. No abstract available.

PMID:
25650542
25.

Response to K. Page et al., 'Costing the Australian National Hand Hygiene Initiative'.

Grayson ML.

J Hosp Infect. 2015 Feb;89(2):137-8. doi: 10.1016/j.jhin.2014.10.009. Epub 2014 Dec 11. No abstract available.

PMID:
25555834
26.

TB-HAART trial.

Kwong JC, Grayson ML.

Lancet Infect Dis. 2015 Jan;15(1):14-5. doi: 10.1016/S1473-3099(14)71032-1. No abstract available.

PMID:
25541161
27.

Impact of vanB vancomycin-resistant enterococcal bacteraemia analysed as a time-varying covariate on length of hospital stay.

Cheah AL, Spelman T, Peel T, Howden BP, Spelman D, Grayson ML, Nation RL, Kong DC.

Epidemiol Infect. 2014 Dec;142(12):2667-71. doi: 10.1017/S095026881400020X.

PMID:
25372228
28.

It's time to move beyond trying to predict mortality using severity assessment tools in community-acquired pneumonia.

Charles PG, Cheng AC, Grayson ML.

Intern Med J. 2014 Nov;44(11):1148. doi: 10.1111/imj.12571. No abstract available.

PMID:
25367733
29.

Doctor, do you have a moment? National Hand Hygiene Initiative compliance in Australian hospitals.

Stewardson AJ, Russo P, Grayson ML.

Med J Aust. 2014 Sep 1;201(5):264-5. No abstract available.

PMID:
25163370
30.

Case-case-control study on factors associated with vanB vancomycin-resistant and vancomycin-susceptible enterococcal bacteraemia.

Cheah AL, Peel T, Howden BP, Spelman D, Grayson ML, Nation RL, Kong DC.

BMC Infect Dis. 2014 Jun 28;14:353. doi: 10.1186/1471-2334-14-353.

31.

Back to basics: hand hygiene and isolation.

Huang GK, Stewardson AJ, Grayson ML.

Curr Opin Infect Dis. 2014 Aug;27(4):379-89. doi: 10.1097/QCO.0000000000000080. Review.

32.

Clinical population pharmacokinetics and toxicodynamics of linezolid.

Boak LM, Rayner CR, Grayson ML, Paterson DL, Spelman D, Khumra S, Capitano B, Forrest A, Li J, Nation RL, Bulitta JB.

Antimicrob Agents Chemother. 2014;58(4):2334-43. doi: 10.1128/AAC.01885-13. Epub 2014 Feb 10.

33.

The growing burden of multidrug-resistant infections among returned Australian travellers.

Chua KY, Grayson ML, Burgess AN, Lee JY, Howden BP.

Med J Aust. 2014 Feb 3;200(2):116-8. No abstract available.

PMID:
24484117
34.

Prevention of peripheral intravenous catheter-related bloodstream infections: the need for routine replacement.

Stuart RL, Grayson ML, Johnson PD.

Med J Aust. 2013 Dec 16;199(11):751. No abstract available.

PMID:
24329641
35.

Is fosfomycin a potential treatment alternative for multidrug-resistant gram-negative prostatitis?

Gardiner BJ, Mahony AA, Ellis AG, Lawrentschuk N, Bolton DM, Zeglinski PT, Frauman AG, Grayson ML.

Clin Infect Dis. 2014 Feb;58(4):e101-5. doi: 10.1093/cid/cit704. Epub 2013 Oct 28.

PMID:
24170195
36.

Assessment of the BD GeneOhm MRSA ACP assay using combined swabs for the detection of methicillin resistant Staphylococcus aureus (MRSA) colonisation.

Grabsch EA, Xie S, Szczurek PB, Grayson ML, Howden BP.

Pathology. 2013 Oct;45(6):612-4. doi: 10.1097/PAT.0b013e3283653b48. No abstract available.

PMID:
24018809
37.

Genomic insights to control the emergence of vancomycin-resistant enterococci.

Howden BP, Holt KE, Lam MM, Seemann T, Ballard S, Coombs GW, Tong SY, Grayson ML, Johnson PD, Stinear TP.

MBio. 2013 Aug 13;4(4). pii: e00412-13. doi: 10.1128/mBio.00412-13.

38.

Electronic estimations of renal function are inaccurate in solid-organ transplant recipients and can result in significant underdosing of prophylactic valganciclovir.

Trevillyan J, Angus P, Shelton E, Whitlam J, Ierino F, Pavlovic J, Gregory D, Urbancic K, Torresi J, Testro A, Grayson ML.

Antimicrob Agents Chemother. 2013 Aug;57(8):4058-60. doi: 10.1128/AAC.00375-13. Epub 2013 Jun 3.

39.

Peripheral intravenous catheter-associated Staphylococcus aureus bacteraemia: more than 5 years of prospective data from two tertiary health services.

Stuart RL, Cameron DR, Scott C, Kotsanas D, Grayson ML, Korman TM, Gillespie EE, Johnson PD.

Med J Aust. 2013 Jun 3;198(10):551-3.

PMID:
23725270
40.

Genomic analysis of teicoplanin resistance emerging during treatment of vanB vancomycin-resistant Enterococcus faecium infections in solid organ transplant recipients including donor-derived cases.

Holmes NE, Ballard SA, Lam MM, Johnson PD, Grayson ML, Stinear TP, Howden BP.

J Antimicrob Chemother. 2013 Sep;68(9):2134-9. doi: 10.1093/jac/dkt130. Epub 2013 Apr 23.

PMID:
23612571
41.

A timely reminder about the concomitant use of fusidic acid with statins.

Cowan R, Johnson PD, Urbancic K, Grayson ML.

Clin Infect Dis. 2013 Jul;57(2):329-30. doi: 10.1093/cid/cit236. Epub 2013 Apr 15. No abstract available.

PMID:
23588554
42.

The incidence of HBV and HCV infection in Australian travelers to Asia.

Johnson DF, Ratnam I, Matchett E, Earnest-Silveria L, Christiansen D, Leder K, Grayson ML, Torresi J.

J Travel Med. 2013 May-Jun;20(3):203-5. doi: 10.1111/jtm.12029.

43.

Enterococcal bacteraemia: factors influencing mortality, length of stay and costs of hospitalization.

Cheah AL, Spelman T, Liew D, Peel T, Howden BP, Spelman D, Grayson ML, Nation RL, Kong DC.

Clin Microbiol Infect. 2013 Apr;19(4):E181-9. doi: 10.1111/1469-0691.12132. Epub 2013 Feb 7.

44.

Inducible resistance to clindamycin in Staphylococcus aureus: validation of Vitek-2 against CLSI D-test.

Gardiner BJ, Grayson ML, Wood GM.

Pathology. 2013 Feb;45(2):181-4. doi: 10.1097/PAT.0b013e32835cccda.

PMID:
23277176
45.

Significant reduction in vancomycin-resistant enterococcus colonization and bacteraemia after introduction of a bleach-based cleaning-disinfection programme.

Grabsch EA, Mahony AA, Cameron DR, Martin RD, Heland M, Davey P, Petty M, Xie S, Grayson ML.

J Hosp Infect. 2012 Dec;82(4):234-42. doi: 10.1016/j.jhin.2012.08.010. Epub 2012 Oct 25.

PMID:
23103245
46.

Problematic linkage of publicly disclosed hand hygiene compliance and health care-associated Staphylococcus aureus bacteraemia rates: comment.

Grayson ML, Russo PL.

Med J Aust. 2012 Aug 20;197(4):212-4; author reply 214. No abstract available.

PMID:
22900863
47.

A potential "blind spot" in vancomycin treatment studies.

Grayson ML, Charles PG, Howden BP.

Clin Infect Dis. 2012 Jul;55(1):165. doi: 10.1093/cid/cis333. Epub 2012 Mar 29. No abstract available.

PMID:
22460956
48.

Comparative analysis of the first complete Enterococcus faecium genome.

Lam MM, Seemann T, Bulach DM, Gladman SL, Chen H, Haring V, Moore RJ, Ballard S, Grayson ML, Johnson PD, Howden BP, Stinear TP.

J Bacteriol. 2012 May;194(9):2334-41. doi: 10.1128/JB.00259-12. Epub 2012 Feb 24.

49.

Doxycycline vs. macrolides in combination therapy for treatment of community-acquired pneumonia.

Teh B, Grayson ML, Johnson PD, Charles PG.

Clin Microbiol Infect. 2012 Apr;18(4):E71-3. doi: 10.1111/j.1469-0691.2011.03759.x. Epub 2012 Jan 27.

50.

Comparison of immunoglobulin G subclass concentrations in severe community-acquired pneumonia and severe pandemic 2009 influenza A (H1N1) infection.

Gordon CL, Holmes NE, Grayson ML, Torresi J, Johnson PD, Cheng AC, Charles PG.

Clin Vaccine Immunol. 2012 Mar;19(3):446-8. doi: 10.1128/CVI.05518-11. Epub 2012 Jan 11.

Supplemental Content

Loading ...
Support Center